Camp4 Therapeutics (CAMP) Equity Ratio (2023 - 2026)

Camp4 Therapeutics has disclosed Equity Ratio across 4 years of filings, most recently posting 0.29 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.29, down 64.33% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.29 (down 64.33% YoY), and the FY2025 annual result was 0.4, down 49.78% from the prior year.
• Equity Ratio came in at 0.29 for Q1 2026 at Camp4 Therapeutics, down from 0.4 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.82 in Q1 2025 to a low of 7.44 in Q3 2024.
• The 4-year median for Equity Ratio is 0.54 (2025), against an average of 0.74.
• Across the five-year window, Equity Ratio soared 135.81% in 2024 and slumped 64.33% in 2026, its largest moves.
• Camp4 Therapeutics' Equity Ratio stood at 2.25 in 2023, then jumped by 135.81% to 0.81 in 2024, then plunged by 49.78% to 0.4 in 2025, then dropped by 27.63% to 0.29 in 2026.
• The last three Equity Ratio figures came in at 0.29 (Q1 2026), 0.4 (Q4 2025), and 0.68 (Q3 2025), per Business Quant data.